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Abstract
Cancer and inflammation are connected by intrinsic pathways and extrinsic path-
way where the intrinsic pathway is activated by genetic events including mutation, 
chromosomal rearrangement or amplification, and the inactivation of tumor-suppres-
sor genes, as well as the extrinsic pathway, is the inflammatory or infectious conditions 
that increase the cancer risk. On the other hand, introns are non-coding elements of 
the genome and play a functional role to generate more gene products through  splicing 
out, transcription, polyadenylation, mRNA export, and translation. Moreover, introns 
also may act as a primary element of some of the most highly expressed genes in the 
genome. Intron may contain their regulatory function as CRISPR system which is acti-
vated after the demand of specific gene for specific protein formation where those are 
required for gene expression, they go for transcription and rest of them form splicing. 
This chapter will focus on the plausible role of introns to influence the genetic events 
of inflammation-mediated cancer cell development.
Keywords: inflammation, cancer, intron retention, CRISPR, transcription, PcGs
1. Introduction
The functioning links between cancer and inflammation was approached by a 
great scientist and physician Rudolf Ludwing Carl Virchow in 1863 [1–3]. Thereafter, 
for long Virchow’s idea had almost been unevaluated and discussed insufficiently 
[1]. Balkwill and colleagues (2001) supported Virchow’s idea and stated that if 
molecular deregulation is the “match that lights the fire” of cancer, then some types 
of inflammation may act as the fuel that stimulates the flame. For instance, the 
inflammatory process act as a cofactor in malignancy in the bladder, cervical, ovar-
ian, gastric, MALT (mucosa-associated lymphoid tissue) lymphoma, esophageal, 
colorectal, hepatocellular, bronchial, mesothelioma, and Kaposi sarcoma [3].
Currently, it is scientifically proven that inflammation promotes all stages of 
tumor formation as well as the development of cancer where chronic inflamma-
tion or non-resolving inflammation is playing a principal role in the initiation, 
promotion, malignant transformation, invasion and metastasis of cancer [4–9]. 
Interestingly, cancer-related inflammation is representing its 7th position as a 
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cancer hallmark and catching the current research attention in human cancer 
biology [5]. Basically, Inflammation act on cancer development by linking extrinsic 
and intrinsic pathway [9]. The extrinsic pathway develops inflammatory condition 
or microenvironment by inflammatory leukocytes particularly macrophages and 
soluble mediators (vasoactive amines such as histamine and serotonin, peptide such 
as bradykinin, and eicosanoids such as thromboxanes, leukotrienes, and prosta-
glandins) that raises cancer risk [9–11]. Intrinsic pathway is driven by genetic events 
(e.g. oncogenes, genetic aberrations) causing neoplastic transformation, initiate 
the expression of inflammation-related programs which guide the construction 
of an inflammatory microenvironment [11]. Inflammatory system involves the 
dynamic regulations of hundreds of genes and complex transcriptional program 
[12]. Moreover, the gene regulations by intron are often expressed in most of the 
cell through the effects of splicing or specific features [13–15].Recently, several 
scientific reports claim that retained intron deregulates splicing machine in tumor 
transcriptoms [16–18]. Intron retention is considered as mis-splicing in which 
rather than being spliced out intron stays back and retained in mature mRNA [17]. 
However, the broad gap exists in monitoring of introns role in understanding of 
gene expression which could be a powerful tool in biotechnological and therapeutic 
applications. This chapter will cover intron’s role in the development of inflamma-
tion, intron retaining genes causing inflammation to cancer and finally unfolding of 
a hypothesis about CRISPR like machine to monitor introns function.
2. Inflammation to cancer
2.1 Extrinsic pathway
Inflammation is activated by leukocytes which make inflammatory mediators 
in the extrinsic pathway and this pathway is also triggered by various infections 
and toxic agents such as gastric acid reflux, autoimmune disease etc. [9]. Patients 
with inflammatory bowel diseases have an increased chance of getting colorectal 
cancer. As an example, about 43% of patients with ulcerative colitis develop 
colorectal cancer [19]. Moreover, in vivo and in vitro experiments have shown that 
DNA can be damaged by reactive oxygen species (ROS) and nitrogen intermedi-
ates which are known as inflammation generated mediators [20, 21]. For example, 
the enzymes of nitrogen production (iNOS) are overly expressed in many cancer 
cells [22]. It has been shown scientifically that over expressed iNOS involves in 
free radical- mediated DNA damage as well as creates an inflammatory microen-
vironment [23–27]. In a hypoxic atmosphere, a heterodimeric transcription factor 
known as HIF-1 (HIF-1α & HIF-1β) binds to hypoxia regulated genes and triggers 
the activation of iNOS and vascular endothelium growth factor (VEGF) [28, 29]. 
Thus hypoxia-responsive molecules such as HIF-1α & HIF-1β play an integral role 
in tumor and cancer development [30]. Matsumoto et al., 2007 have shown that 
Helicobacter pylori produce cytidinedeaminase (AID) in gastric epithelium which 
induce chronic inflammation mediated cholangiocarcinoma [31, 32].
2.2 Intrinsic pathway
Intrinsic pathway is activated by genetic variation such as proto-oncogene 
activation, inactivated tumor suppressor genes, and chromosomal multiplication 
as well as mutation which develops neoplasia [22]. A gene coding protein namely 
tyrosine kinase RET shows rapid and ample genetic variation in human papillary 
thyroid carcinoma (PTC) and initiates the transcriptional program that links to the 
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development of inflammation [33]. Transcriptome profile is activated by tyrosine 
kinase RET in human papillary carcinoma and comprises with colony-stimulating 
factors (CSFs), interleukin 1β (IL-1β), cyclo-oxygenase 2 (COX2), chemokines 
attacking monocytes and dendritic cells (CCL2 & CCL20), angiogenicchemokines 
(CXCL8), matrix-degrading enzymes and inhibitors, chemokine receptor (CXCR4) 
[34]. For example, patients with lymph nodes metastasis have shown an elevated 
level of tyrosine kinase RET activated inflammatory molecules in their biopsy 
results which demonstrate that genetic events have taken place in the pathogenesis 
of tumor and constructed an inflammatory environment [33–35]. Moreover, Ras 
oncogenes were known to be the most dominant genes that tend to get mutated 
rapidly and play a significant role in tumorigenesis. Ras oncogenes family includes 
KRAS, HRAS, and NRAS and their mutation has been observed in 25–30% of 
tumor specimens which has an impact on the KRAS locus [22]. For instance cervi-
cal cancer has shown that shifting of RAS oncogenes makes a chemokine named 
CXCL8 which participates in tumor development [36, 37]. Furthermore, polycomb 
complex target genes (PcGs) play a salient role in the growth of the embryo and 
aging through epigenetic rearranging. These groups of genes also involve in abnor-
mal DNA methylation and histone modification in cancer cells [38]. As an example, 
Yu H and colleagues (2007) reported that a mouse model with intestinal inflamma-
tion and cancer shows abnormal DNA methylation where over 70% of abnormal 
methylated genes were observed in PcGs [38].
3. Functional role of intron for development of cancer
Intron is defined as any intervening nucleotide sequence that formed splicing at 
the RNA level [39]. Intron was first discovered in 1970s with a traditional views that 
the coding region of eukaryotic genes are interrupted by introns which are spliced 
out from pre mature mRNA transcripts before the formation of mature mRNA 
[39–41]. After the elucidation of intron splicing mechanism, scientist became 
excited about its function on gene expression and speculated that may be introns 
carry out some function like regulation of splicing function, regulation of transcrip-
tion, evolutionary function or coding capacity but there was no clear examples of 
their active functions on gene expression [41]. From the starting 21st century, many 
researches have claimed about the intron function on gene expression or intron 
mediated enhancement of gene expression [13, 42–47]. However, a question remains 
unclear that within the genome, who is responsible to remember or decide which 
intron or parts of nucleotide sequences are necessary to stay within the mature 
mRNA stand for inflammatory gene expression rather than form splicing that 
result in cancer? Current chapter sheds light on the above question and hypothesize 
CRISPR like machine in perspective of inflammation mediated cancer development.
After the discovery of alternative splicing (AS), the transcriptomic and proteomic 
complexity has increases significantly [47, 48]. Recent breakthrough studies in 
high-throughput sequencing have explored a pivotal role of AS in normal biology that 
more than 95% of human multi exonic genes are subject to AS and produce at least 
two alternative isoforms [49, 50]. Moreover, Braunschweig and colleague compared 11 
vertebrate species and observed that about 50–75% of multi-exonic genes are affected 
by intron retention (IR) which is one kind of AS [47, 48, 51]. While another study 
showed that IR affects near about 80% of protein coding genes in humans [52]. Some 
scientific reports also considered IR as a harmful process for the body by slowing 
down splicing kinetics and delaying the onset of gene expression, by raising pre-
mRNA degradation in the nucleus through nuclear exosomes and finally by enhancing 
cytoplasmic pre-mRNA degradation through nonsense-mediated decay [51, 53, 54]. 
Inflammation
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This statement is also supported by the Green and colleague’s research as the genes 
that encoded the regulators of macrophage transcription, signaling inflammation, 
and phagocytosis has increased their expression when the IR events decreased [55]. As 
it is known, that intron retention (IR) is the process where instead of typically being 
spliced out, the introns remain intact in the mature mRNAs and thus whole process of 
IR supposedly has numerous physiological drawbacks resulting in different diseases 
[47, 48].Currently, many researchers strongly claim that IR is a key mechanism to 
control gene expression during the development, differentiation and activation of 
several types of mammalian cell [56–63]. A recent study by Green and colleague 
claimed that intron retention affected the expression of key genes (ID2, IRF7, ENG, 
and LAT) involved in the development and function of macrophages those are the key 
inflammatory regulator [55]. So IR gene might be acting as one of the major causes of 
inflammation mediated cancer development (Table 1).
3.1 TGIF2 gene
PCR technique revealed two alternate splice forms of TGIF2 gene that were 
found in mice. The coding sequence of TGIF2 gene both in human and mice 
consists with intron that is retained [78]. The splicing phenomenon depends on the 
TGIF2 coding sequence where both splice forms encoded for an active transcrip-
tional repressor protein that is used to repress independent TGFβ and dependent 
TGFβ transcription [79]. Moreover, Melhuish and colleague have shown that the 
transcriptional core-repressor mSin3 interacts with human and miceTGIF2 and 
also revealed that the TGIF2 gene retains intron at a negligible amount which is not 
spliced out from human mRNA but a bigger amount is spliced out from the mice 
and thus correlated with variant cancers [79]. These findings are also supported 
by the study of Imoto et al., 2020 where the authors claimed that amplification 
and over-expression of TGIF2 gene lead to ovarian cancer [80]. The TGIF2 gene is 
located in chromosome 20q11.2–12 [80]. Often in solid human tumors, it has been 
observed that the long arm of chromosome 20 is highly amplificated [64]. Rapid 
amplification of TGIF2 in chromosome 20 leads to ovarian cancer which is observed 
in the cell lines of ovaries [80]. It is known that inflammation helps to grow tumor 
as well as development of cancer [4]. So the TGIF2 gene might have induced inflam-
mation during the tumourigenesis later on which turned into ovarian cancer.
3.2 EBNA-3 gene
EBNA-3 gene involves in multiple regulation during their expression due to IR 
retention. For instance, a study by Kienzle et al., (1999) showed that a stop codon 
might be inserted into a frame shift because of IR and thus the translation process 
could be stopped as a premature termination of EBNA-3 gene [81]. Moreover, it was 
depicted that IR can change the expression pattern of the EBNA-3 gene in human 
B-lymphocyte where its protein plays a pivotal role in cell proliferation and trans-
formation. They also play a censorious part in the development of lymphoma [82]. 
Patients with chronic inflammation because of autoimmune disorder have a higher 
risk to develop lymphoma [83]. So, herein could be a strong possibility to influence 
inflammation mediated lymphoma development by EBNA-3 gene.
3.3 APOE4
The expression of the APOE4 isoform shows a relation between intron retention 
and Alzheimer’s disease (AD). The prevalence of AD was longitudinally associ-
ated with a reduced risk of cancer where the cancer incidence was associated with 
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Gene name Protein name General function Types of cancer that 
is developed by IR 
gene
Abnormal function References
TGIF2 TGFB Induced Factor 
Homeobox 2
TGF-β-induced factor homeobox 2 (TGIF2) is known to be 
transcription regulator that plays significant role in the regulation of 
development and cell fate decisions. Abnormal expression of TGIF 
family proteins has been noticed in numerous cancers which include 
ovarian, esophageal, and colorectal cancers.
Ovarian cancer Over expressed [64, 65]
EBNA-3 Epstein–Barr nuclear 
antigen 3
This gene plays a principle role for activation and immortalization of 
human B-cells. Represses transcription of viral promoters TP1 and Cp 
interact with RBPJ and also inhibits the EBNA2-mediated activation of 
these promoters. As Cp is known to be the promoter for all the EBNA 





APOE4 Apolipoprotein E4 This gene gives instructions to make a protein called apolipoprotein 
E. This protein combines with fats (lipids) in the human body to 
form molecules called lipoproteins. Lipoproteins in body package 
cholesterol and other fats and transfer them by the bloodstream.
Breast cancer Increased frequency [68, 69]
EGFR Epidermal growth 
factor receptor
Receptor tyrosine kinase binding ligands of the EGF family. They 
activate a lot of signaling cascades to transform them extracellular cues 
into appropriate cellular responses.
Lung cancer Mutation or cell damage [70, 71]
ROS1 Receptor Tyrosine 
Kinase
ROS1 is a proto-oncogene which encodes a type I integral membrane 
protein with receptor tyrosine kinase (RTK) activity. It is a member 
of the insulin receptor family and it is also involved in downstream 












Gene name Protein name General function Types of cancer that 
is developed by IR 
gene
Abnormal function References
RUNX1 RUNX Family 
Transcription Factor 1
The protein encoded by this gene represents the alpha subunit 
of CBF(Core binding factor) and is thought to be involved in the 
development of normal hematopoiesis. Chromosomal translocations 
involving by this gene are well-documented and have been associated 
with several types of leukemia. Three transcript variants encoding 




TP53 Tumor Protein 53 TP53 gene gives instructions for making a protein called tumor protein 
p53. This protein acts as a tumor suppressor, which means that it 
regulates cell division by keeping cells from growing and dividing 
(proliferating) too fast or in an uncontrolled way
Breast cancer, 
bone and soft 
tissue sarcomas, 




cancer and colorectal 
cancer




List of intron retention genes and their functions.
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a reduced risk of AD [84]. Significant scientific evidence has shown that APOE4 
could able to aggravate more neurodegeneration, tau pathology and inflammation 
[85–87]. Liestøl et al., 2000 have observed that genotypes of APOE4 increases the 
risk of cancer in patients with immunodeficiency. Interestingly, 24.6% of APOE4 
alleles have been found in variant cancer cases where 13.5% were found in noncan-
cerous cases [88]. As the higher frequency of APOE4 increases the risk of cancer, it 
also worsens inflammation. It might be possible that APOE4 may initiate inflamma-
tion and by making it worse, it causes cancer in people with immunodeficiency.
3.4 EGFR, ROS1, RUNX1
It was claimed that 2340 and 1422 genes show tumor-specific and normal tissue-
specific retention events respectively [89, 90]. For example, EGFR, ROS1, RUNX1 
play salient roles in carcinogenesis [72, 89]. ROS1 gene fusion has been observed 
in a substantial number of malignancies which comprises ovarian cancer, cholan-
giocarcinoma, inflammatory myofibroblastic tumor, colorectal, and angiosarcoma 
[72]. Abnormal EGFR expression can initiate different types of respiratory diseases 
such as inflammation mediated lung fibrosis, cancer, and multiple hypersecretory 
diseases comprising COPD, asthma and cystic fibrosis [91]. Furthermore, RUNX1 
mutation has been observed in numerous malignancies in myeloid and lymphoid 
cell [92]. Bellissimo et al., 2020 showed that RUNX1 regulates the signaling path-
ways of TLR1/2 and TLR4 and with the help of neutrophils it can produce inflam-
matory cytokines as well as develop inflammation mediated leukemia [74].
3.5 TP53
Intron retention frequency may be responsible to inactive tumor suppres-
sor genes in many cancers cell [93]. Study revealed that in cancerous condition, 
retained intron transcript exits in NMD pathway and inactivates the TP53 gene. 
Additionally, TP53 gene provides instruction to code for a protein named p53 which 
can produce pro-inflammatory cytokines [92]. Mutation of p53 can cause inflam-
mation mediated cancer [94].
4. Phylogenetic tree analysis of IR gene, PcGs and Ras oncogene
The evolutionary history and relationship of an organism or group of species are 
named phylogeny. Phylogeny depicts the connection of an organism. Phylogenetic 
relationships give information on shared common ancestry but not obligatory how 
organisms are similar or different. Phylogenic tree analysis of all genes those are 
performing intron retention scenario, PcGs and Ras oncogenes (Figures 1–3) has 
Figure 1. 
Phylogenetic tree of intron retaining (IR) genes.
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done to find out the relation among the genes. MEGA X software has been used to 
construct the phylogenic tree to understand the relation among all the cancers genes 
(Tables 1 and 2).
Figure 1 demonstrates that the vertical line on the left side is the common 
ancestor or the root of the seven gene sequences from which the genes have been 
evolved in a period. The evolution period can be explained through the horizontal 
lines near the sequences. The small length of lines before sequences means the 
sequences evolved in a short period whereas the long length of lines means longer 
time was needed for the sequences to be evolved. The common ancestor or root 
has been divided into two branch points. From the first branch point total of five 
sequences have been modified which were RUNX1, APOE4, EBNA-3(USP46), 
ROS1, and TP53. From the second branch point, two sequences have been evolved 
TGIF2 and EGFR. The phylogenetic tree has three separate clades. Clade means a 
variety of species that include all the descendants of a common ancestor. In the first 
clade, the first two sequences of genes RUNX1 and APOE4 are closer to the ancestor 
than EBNA-3 as they are from the same node. In the second clade, among ROS1 and 
Figure 3. 
Phylogenic tree among IR gene, RAS oncogenes and PcGs.
Figure 2. 
Phylogenic tree between RAS oncogenes and PcGs.
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BMI 1 B-lymphoma Moloney 
murine leukemia virus 
insertion region-1
This gene functions through chromatin remodeling as a 
principle epigenetic repressor of numerous regulatory genes 
involved in embryonic development and self-renewal in 
somatic stem cell and also plays a median role in DNA damage 
repair. It is an oncogene and abnormal expression is related 
with multiple cancers and resistance to certain chemotherapies.
Gastric, ovarian, breast, head and neck, 
pancreatic and lung cancer, primary 





CBX7 Chromobox proteins 7 This gene encodes a protein that comprises the CHROMO 
(CHRomatin Organization MOdifier) domain. It is thought to 
control the lifespan of several normal human cells.
Breast, Thyroid, Colorectal, Pancreas, 






This gene gives instructions for making an enzyme called 
phenylalanine hydroxylase. This enzyme is responsible for the 
primary step in processing phenylalanine, which is a building 
block of proteins (an amino acid) obtained through the diet.
Liver cancer Down 
regulation
[99, 100]
RING 1 Ring Finger 1A This gene encodes proteins characterized by a RING domain, 
a zinc-binding motif related to the zinc finger domain. The 
gene product can bind DNA and can act as a transcriptional 
repressor. It is related with the multimericpolycomb group 
protein complex.
Hepatocellular and colorectal carcinomas Down 
regulation
[101, 102]
MEL18 Polycomb group ring 
finger 2
Mel-18 functions as a tumor suppressor via downregulation of 
BMI1. Single Nucleotide Polymorphism and down regulation of 
Mel-18 is associated with prostate cancer.





EZH2 Enhancer of zeste 
homolog-2
The EZH2gene makes an enzyme methyltransferase. 
Histone methyltransferases modify proteins called histones, 
which are structural proteins that bind to DNA and shape 
chromosomes. Addition of a molecule (methyl group) to 
histones (methylation), histone methyltransferases can turn off 
(suppress) the activity of certain genes, an essential process in 
normal development.
Breast cancer, Colorectal cancer, 
















EED Embryonic ectoderm 
development
This gene encodes a member of the Polycomb-group family. 
It maintains the transcriptional repressive state of genes 
over successive cell generations. This protein interacts with 
enhancer of zeste 2, the cytoplasmic tail of integrin beta7, 
immunodeficiency virus type 1 (HIV-1) MA protein, and 
histone deacetylase proteins. This protein mediates repression 
of gene activity through histone deacetylation, and may act as a 
specific regulator of integrin function. Two transcript variants 
encoding distinct isoforms have been identified for this gene.
Colorectal Cancer, acute myeloid 





SUZ12 suppressor of zeste 12 
homolog
This zinc finger gene has been detected at the breakpoints of a 
recurrent chromosomal translocation reported in endometrial 
stromal sarcoma. Recombination of these breakpoints results in 
the fusion of this gene and JAZF1. The protein encoded by this 
gene comprises a zinc finger domain in the C terminus of the 
coding region
Colorectal, ovarian and non-small lung 





PCL3 PHD fing protein 19 PHF19 promotes the proliferation, migration, and 
chemosensitivity of glioblastoma to doxorubicin through 
modulation of the SIAH1/beta-catenin axis. Human PCL3 has 
an oncogenic role in hepatocellular carcinoma by activating the 
beta-catenin/IL6 signaling axis to promote metastasis
Hepatocellular carcinoma, glioma, 





TP53 TumourProtein 53 Functions are the same as discussed in Table 1 Types of cancers are the same as 
discussed in Table 1
Gene 
alternation 
or deletion or 
mutation
[76, 77]
KRAS Kirsten rat sarcoma viral 
oncogene
The KRAS gene gives instructions for making a protein called 
K-Ras which is a part of a signaling pathway known as the RAS/
MAPK pathway. The protein relays signals from outside the cell 
to the cell’s nucleus
Non-small cell lung cancer, colorectal 
cancer, and pancreatic cancer
Mutation [114, 115]
Table 2. 
List of PcGs genes and their functions.
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TP53, ROS1 is closer to the root as its horizontal line is smaller than the TP53 ones. 
In the third clade, EGFR is much closer to the root than TGIF2 as its horizontal line 
is smaller and close to the ancestor than TGIF2.
Figure 2 depicts that both type of cancer genes (RAS oncogene and PcGs) were 
evolved from a common root or ancestor. The tree demonstrates that BMI 1, HRAS, 
SUZ12, and EED had been sharing the most recent ancestor but BMI 1, HRAS, and 
SUZ12 remain closer than EED as they share the same root. Interestingly, BMI 1 & 
EZH2 from PcGs and HRAS & NRAS from Ras oncogene are closely related to each 
other respectively where they are from different group’s gene. The following three 
genes PHF19/PCL3, PH and TP53 were from the same clade and they are near to one 
another. The last four genes CBX7, KRAS, RING 1 and MEL 18(PCGF2) were from 
the same clade as they share the most common ancestor.
Figure 3 demonstrates that all the genes were evolved from a common ancestor. 
The IR gene APOE 4 and ROS1 are closely related each other as expected. However 
interestingly, IR gene EBNA-3shares the common ancestor with PCGF(MEL18). So 
herein might be chances for MEL18 or PCGF2 gene to develop inflammation medi-
ated cancer by the influencing of IR.
5.  Hypothesis: CRISPR like function might be a functioning model of 
intron
CRISPR-Cas9 is also known as a genome-editing tool where CRISPR stands for 
“Clustered Regularly Interspaced Short Palindromic Repeats and Cas9 is an enzyme 
that cuts foreign DNA [116]. In the 21st century, CRISPR-Cas9 is being used 
immensely in medical technology to edit, remove or add a gene to correct genetic 
defects [116]. CRISPR has conformed from the natural defense mechanism of bac-
teria, archaea and developed an immune system by CRISPR loci [116]. CRISPR and 
Cas9 enzyme serve as an immune guard and provide safety against bacteriophage, 
viruses, and foreign invaders [117–119]. The immunization process after invading 
foreign genetic elements, a small fragments of foreign DNA are integrated into the 
CRISPR repeat-spacer array within the host chromosome as new spacers. Thus, a 
genetic record of prior infection will save into the host body that enables to prevent 
future invasion of the same invader [120, 121] (Figure 4).
The nucleotide repeats and spacers are main two component of CRISPR. 





a small portion of DNA present in the CRISPR region. Destruction of foreign invad-
ing DNA or RNA occurs by Cas9 enzyme. If in future, the foreign body again attacks 
the organism, they fight it off as they have the virus or foreign invader’s DNA from 
beforehand and thus they recognize it and kill it [121]. So in CRISPR biology, spacer 
acts as a responsible sequence to remember or decide which foreign body needs to be 
killed where Cas9 enzyme plays a pivotal role. According to our hypothesis, intron 
network might work as CRISPR like functioning model.
According to the section 3, it is confirmed that IR have the ability to influence 
inflammation mediated cancer development. From the CRISPR function it is clear 
that according to the demand of the cell, CRISPR can get activated. It might be pos-
sible that according to the demand of the abnormal cells, intron retention may form 
to confirm inflammation mediated malignancy state (Figure 5). Moreover, our phy-
logenetic tree analysis depicts that PcGs, RAS oncogenes, and intron retaining genes 
are related to each other and they all share a common ancestor. As all three categories 
of genes initiate cancer development in humans, it might be possible that PcGs and 
RAS oncogenes can express themselves as intron retaining genes or vice versa.
6. Conclusions
Cancer is a genetic disease and is one of the leading causes of death around the 
world. As a genetic event, the intron retention causes inflammation as well as the 
development of cancer cells. So far, it is clear that the intron is spliced away during 
gene expression while exons remain and express the genes. However, the retention 
of introns is an unlikely phenomenon that differs from the common hypothesis 
and appears anomalous. The genes involved in retaining intron have a carcinogenic 
effect. It may be speculated that some nucleotide sequence whether it is coding or 
non-coding region could function as a memory sequence, hence are able to remem-
ber intronic sequence as like spacer responsibility of CRISPR system and would 
only be functioning according to the demand of the cell. Future in depth analysis on 
intron retaining genes is required to explore their effect on inflammation and cancer.
Figure 5. 
Illustration of retained intron in the gene causing mutation which leads to inflammation and tumorigenesis 
resulting in development of cancer.
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Appendices and nomenclature
VEGF Vascular endothelium growth factor




PcGs Polycomb complex target genes
AD Alzheimer’s disease
CRISPR Clustered Regularly Interspaced Short Palindromic Repeats
AS Alternative splicing
IR Intron retention
COPD Chronic obstructive pulmonary disease
MALT Mucosa-associated lymphoid tissue
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